Challenges in the treatment of convulsive status epilepticus
Highlights • There are news in the treatment of convulsive status epilepticus (CSE). • In pre-hospital setting, rapidity of administration is most important. • In established CSE phenytoin is not a first choice. • In refractory CSE midazolam and propofol are preferable. • Immunosuppression should be...
Saved in:
Published in | Seizure (London, England) Vol. 47; pp. 17 - 24 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights • There are news in the treatment of convulsive status epilepticus (CSE). • In pre-hospital setting, rapidity of administration is most important. • In established CSE phenytoin is not a first choice. • In refractory CSE midazolam and propofol are preferable. • Immunosuppression should be considered in refractory CSE of unknown origin. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1059-1311 1532-2688 |
DOI: | 10.1016/j.seizure.2017.02.015 |